The incidence of human papillomavirus-positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) is rising rapidly and has exceeded cervical cancer to become the most …

Simple Summary Circulating human papillomavirus DNA is a promising tool in the
management of HPV-positive oropharyngeal cancer. The potential use of this tool will …

Importance There is growing interest in the use of circulating plasma tumor human
papillomavirus (HPV) DNA for diagnosis and surveillance of patients with HPV-associated …

The NavDx® blood test analyzes tumor tissue modified viral (TTMV)-HPV DNA to provide a
reliable means of detecting and monitoring HPV-driven cancers. The test has been clinically …

Simple Summary Despite salvage surgery being a key treatment option for recurrent
oropharyngeal squamous cell carcinoma, it is unclear how human papillomavirus (HPV) …

Background High-risk human papillomavirus (HPV) is a primary cause of an increasing
number of oropharyngeal squamous cell carcinomas (OPSCCs). The viral etiology of these …

Importance Head and neck squamous cell carcinoma is a highly lethal cancer that is often
associated with human papillomavirus (HPV). Recent studies have shown promise in the …

Background Our aim was to evaluate the efficacy and anti-cancer action of a precision
medicine approach involving a novel SIRT1-dependent pathway that, when disrupted, leads …

Posttreatment imaging surveillance of head and neck cancer is challenging owing to
complex anatomic subsites and diverse treatment modalities. Early detection of residual …

Importance The utility of preoperative circulating tumor tissue-modified viral human
papillomavirus DNA (TTMV-HPV DNA) levels in predicting human papillomavirus (HPV) …